Tag
FDA
-
FDA Approves Pfizer’s Talzenna Combo for HRR-Mutated Metastatic Prostate Cancer
Pfizer’s PARP inhibitor plus enzalutamide is now approved for HRR-mutated metastatic prostate cancer before resistance sets in. In TALAPRO-3 it cut the…
-
FDA Approves Hibsago, a 24-Week Shot That Lets Some Hepatitis B Patients Stop
GSK’s bepirovirsen is the first antisense drug approved for chronic hepatitis B. In trials, 19% of patients kept the virus controlled after…